Latest news
Loading news…
Petra Pharma
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 MediumHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals. New York, United States Founded 2016 11-50 employees For Profit
Petra Pharma is a clinical-stage pharmaceutical company developing a diverse portfolio of novel therapies.
Petra Pharma was acquired by Eli Lilly in 2020 for $175M.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
3
Patents
21
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
- Valuation range
- $100M to $500M
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 3
- Active products
- 12
- Patents granted
- 21
- Trademarks
- 0
- Top patent class
- Organic Chemistry
- IT spend
- $119K
Company Info
- Founded
- 2016
- Employees
- 11-50
- Operating status
- Active
- Company type
- For Profit
- Org types
- company
- Founders
- 2
- News articles
- 23
- HQ
- New York, United States
- Region
- Greater New York Area, East Coast, Northeastern US
- Exit date
- May 1, 2020
Signals & Scores
- Heat score
- Medium
- Growth score
- Low
- Trend (7d)
- -0.1
- Trend (30d)
- 1.3
- Trend (90d)
- 1.1
3
professional contacts at Petra Pharma
Contact execs at Petra Pharma →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Petra Pharma
Loading news…
FAQs about Petra Pharma
People who checked this page also checked these
Browse the full Acquirezy directory.